On Tuesday, Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $60.6 which represents a decrease of $-2.37 or -3.76% from the prior close of $62.97. The stock opened at $62.46 and ...
Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's ...
In recent trading, Viking Therapeutics Inc (VKTX) stock price has shown some volatility, fluctuating -6.04% over the last five trades and 9.66% over the past 30 trades. This represents a notable shift ...
Viking Therapeutics reported an 8.2% weight loss with VK2735, but a sell-off followed. Read why VKTX stock's long-term ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Truist Financial analyst Joon Lee assigned a Buy rating to the stock today. The company’s shares closed last Friday at $72.88. Lee covers ...
Barchart on MSN14d
Up 285% YTD, Is It Too Late to Buy This Biotech Stock?On Oct. 24, VKTX surged by 21% after announcing better-than-expected third-quarter results, including positive updates on its ...
Investing.com - Viking Therapeutics Inc (NASDAQ: VKTX) reported fourth quarter EPS of $-0.260, $0.03 worse than the analyst estimate of $-0.230. Revenue for the quarter came in at ...
At the close in NYSE,... Viking Therapeutics (NASDAQ:VKTX) has filed a prospectus for a $450M mixed shelf offering.Now read: Rounds Report: Aveo Catches A Big Payday With NHSScotland Approval Of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback